Caprolactam Chemicals Limited (BOM:507486)
India · Delayed Price · Currency is INR 70.09
-0.29 (-0.41%)
At close: Jan 20, 2026
Caprolactam Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 88.3 | 67.4 | 69.57 | 98.42 | 20.69 | 63.09 | Upgrade |
Other Revenue | - | - | 0 | - | - | - | Upgrade |
| 88.3 | 67.4 | 69.57 | 98.42 | 20.69 | 63.09 | Upgrade | |
Revenue Growth (YoY) | 53.24% | -3.13% | -29.30% | 375.71% | -67.21% | -3.13% | Upgrade |
Cost of Revenue | 17.97 | 17.13 | 8.88 | 11.37 | 6.03 | 4.91 | Upgrade |
Gross Profit | 70.33 | 50.27 | 60.7 | 87.05 | 14.66 | 58.18 | Upgrade |
Selling, General & Admin | 4.08 | 3.71 | 3.88 | 3.77 | 2.54 | 3.1 | Upgrade |
Other Operating Expenses | 42.19 | 31.32 | 33.37 | 36.51 | 13.8 | 32.68 | Upgrade |
Operating Expenses | 62.14 | 50.92 | 53.07 | 51.81 | 26.69 | 46.44 | Upgrade |
Operating Income | 8.2 | -0.65 | 7.62 | 35.23 | -12.03 | 11.74 | Upgrade |
Interest Expense | -7.14 | -6.29 | -4.98 | -5.68 | -2.76 | -2.97 | Upgrade |
Interest & Investment Income | 0.1 | 0.1 | 0.08 | 0.15 | 0.06 | 0.14 | Upgrade |
Other Non Operating Income (Expenses) | 0.21 | - | -0 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 1.36 | -6.84 | 2.72 | 29.71 | -14.74 | 8.91 | Upgrade |
Pretax Income | 1.36 | -6.84 | 2.72 | 29.71 | -14.74 | 8.91 | Upgrade |
Income Tax Expense | 1.31 | 0.25 | 0.75 | 4.22 | -1.92 | 2.41 | Upgrade |
Net Income | 0.05 | -7.09 | 1.97 | 25.49 | -12.82 | 6.51 | Upgrade |
Net Income to Common | 0.05 | -7.09 | 1.97 | 25.49 | -12.82 | 6.51 | Upgrade |
Net Income Growth | - | - | -92.25% | - | - | -31.60% | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade |
EPS (Basic) | 0.01 | -1.54 | 0.43 | 5.54 | -2.79 | 1.41 | Upgrade |
EPS (Diluted) | 0.01 | -1.54 | 0.43 | 5.54 | -2.79 | 1.41 | Upgrade |
EPS Growth | - | - | -92.25% | - | - | -31.81% | Upgrade |
Free Cash Flow | -12 | -22.35 | 1.7 | -12.98 | -17.06 | 7.62 | Upgrade |
Free Cash Flow Per Share | -2.61 | -4.86 | 0.37 | -2.82 | -3.71 | 1.66 | Upgrade |
Gross Margin | 79.65% | 74.59% | 87.24% | 88.45% | 70.84% | 92.22% | Upgrade |
Operating Margin | 9.28% | -0.96% | 10.96% | 35.80% | -58.15% | 18.61% | Upgrade |
Profit Margin | 0.06% | -10.51% | 2.84% | 25.90% | -61.97% | 10.31% | Upgrade |
Free Cash Flow Margin | -13.59% | -33.16% | 2.45% | -13.19% | -82.44% | 12.08% | Upgrade |
EBITDA | 24.31 | 15.24 | 23.45 | 46.76 | -1.68 | 22.4 | Upgrade |
EBITDA Margin | 27.53% | 22.61% | 33.70% | 47.51% | -8.14% | 35.50% | Upgrade |
D&A For EBITDA | 16.11 | 15.89 | 15.82 | 11.53 | 10.35 | 10.65 | Upgrade |
EBIT | 8.2 | -0.65 | 7.62 | 35.23 | -12.03 | 11.74 | Upgrade |
EBIT Margin | 9.28% | -0.96% | 10.96% | 35.80% | -58.15% | 18.61% | Upgrade |
Effective Tax Rate | 96.03% | - | 27.53% | 14.21% | - | 27.01% | Upgrade |
Revenue as Reported | 88.61 | 67.49 | 71.37 | 98.57 | 24.74 | 64.02 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.